SE7702370L - Tienamycinderivat - Google Patents

Tienamycinderivat

Info

Publication number
SE7702370L
SE7702370L SE7702370A SE7702370A SE7702370L SE 7702370 L SE7702370 L SE 7702370L SE 7702370 A SE7702370 A SE 7702370A SE 7702370 A SE7702370 A SE 7702370A SE 7702370 L SE7702370 L SE 7702370L
Authority
SE
Sweden
Prior art keywords
toxic
thienamycin
pharmaceutically acceptable
acceptable salts
sulphoxide
Prior art date
Application number
SE7702370A
Other languages
English (en)
Inventor
B G Christensen
E Walton
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7702370L publication Critical patent/SE7702370L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7702370A 1976-03-16 1977-03-03 Tienamycinderivat SE7702370L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66732376A 1976-03-16 1976-03-16

Publications (1)

Publication Number Publication Date
SE7702370L true SE7702370L (sv) 1977-09-17

Family

ID=24677763

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7702370A SE7702370L (sv) 1976-03-16 1977-03-03 Tienamycinderivat

Country Status (8)

Country Link
JP (1) JPS52111591A (sv)
CH (1) CH630086A5 (sv)
DE (1) DE2711223A1 (sv)
DK (1) DK90277A (sv)
FR (1) FR2344558A1 (sv)
GB (1) GB1551672A (sv)
NL (1) NL7702183A (sv)
SE (1) SE7702370L (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1577725A (en) * 1976-06-30 1980-10-29 Beecham Group Ltd Azetidinone derivatives
EP0002564B1 (en) * 1977-11-12 1984-06-20 Beecham Group Plc Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates
JPS61236785A (ja) * 1985-04-15 1986-10-22 Sankyo Co Ltd アゼチジノン誘導体

Also Published As

Publication number Publication date
NL7702183A (nl) 1977-09-20
FR2344558B1 (sv) 1980-06-13
DK90277A (da) 1977-09-17
GB1551672A (en) 1979-08-30
CH630086A5 (en) 1982-05-28
FR2344558A1 (fr) 1977-10-14
DE2711223A1 (de) 1977-10-27
JPS52111591A (en) 1977-09-19

Similar Documents

Publication Publication Date Title
ES477591A1 (es) Procedimiento para la obtencion de preparados farmaceuticos que contienen un derivado de cefem.
FI830704A0 (fi) Kefalosporinderivat och foerfarande foer deras framstaellning
SE7604052L (sv) Nya erytromycinderivat och forfarande for framstellning derav
GB1544872A (en) 4-hydroxyphenylalkanolamine derivatives and preparation thereof
ES476109A1 (es) Procedimiento para la preparacion de derivados de cefalospo-rina
ATE7229T1 (de) Cephalosporinderivate und deren herstellung.
SE7411243L (sv)
SE7702370L (sv) Tienamycinderivat
IE44069L (en) Noroxymorphones
ES517995A0 (es) Un procedimiento para la preparacion de un compuesto de hidroxibencilaminobenceno, dotado de propiedades antiinflamatorias.
ATE33390T1 (de) Antibiotikum, dessen herstellung sowie dessen verwendung.
SE7909501L (sv) Cefalosporin-antibiotika
SE7612963L (sv) Tienamycinderivat
ES505430A0 (es) Procedimiento para la preparacion de 3-0-desmenlistamicina b.
SE7612961L (sv) Tienamycinderivat
NO833807L (no) Cefalosporinderivater og fremgangsmaater for deres fremstilling
SE7903200L (sv) Farmaceutiskt, serskilt diuretiskt verksamt preparat for parenteral administration
AU562643B2 (en) N-arylpiperazine derivatives
FR2435481B1 (sv)
ZA812541B (en) Benzothiazole derivatives and salts thereof,processes for their preparation,and their use as sweetening agents
GB1028563A (en) Antibacterial derivative of 7-aminocephalosporanic acid
JPS57185292A (en) Cephem derivative and manufacture
ES430676A1 (es) Procedimiento para la preparacion de 1,2,4-tiadiazolo- (2,3-a) bencimidazoles-2-sustituidos.
SE8303727L (sv) Cefalosporinantibiotika
SE7905520L (sv) Cefalosporinderivat

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7702370-3